drugset
drugset / Trial / NCT04464681

Multiple Dose Escalation Study of M201-A in Healthy Japanese Subjects

NCT04464681 ↗

Phase 1 Completed 18 enrolled Kitasato University Aetas Pharma Co. Ltd. · collab
RandomizedSequentialQuadruple-blindTreatment

Summary

This Phase I is designed to evaluate the safety, tolerability and pharmacokinetics of multiple ascending doses of M201-A administered by multiple continuous intravenous injection in Healthy Japanese subjects.

Timeline

Start
2020-03-30
Primary completion
2020-11-28
Completion
2020-11-30

Drugs

EvaluationDrugModalityDoseRoute
Subject M201-A Unknown — Intravenous

Indications

No indication recorded.